Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Howard A. Kelly's research focuses on gynecological health, with recent work investigating therapeutic vaccines for cervical intraepithelial neoplasia (CIN2/3). This includes a Phase 2 clinical trial for PepCan, a peptide-based human papillomavirus (HPV) therapeutic vaccine, and a comparison with Candida adjuvant alone. Kelly has also explored the use of virtual reality technology to manage patient anxiety and reduce opioid use during brachytherapy procedures for gynecological cancer patients. His scholarly contributions are reflected in a h-index of 11, with 141 total publications and over 1,000 citations. He has collaborated with researchers such as Charles M. Quick, David W. Ussery, Michael S. Robeson, and William W. Greenfield at the University of Arkansas for Medical Sciences, co-authoring multiple publications with each.
Metrics
- h-index: 11
- Publications: 141
- Citations: 1,002
Selected Publications
-
A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025)
-
GSOR03 Presentation Time: 5:10 PM (2024)
-
A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023)
Collaboration Network
Top Collaborators
- Using Virtual Reality Technology to Improve Patient Anxiety and Reduce Opioids Use during HDR Brachytherapy Procedure for Patients with Gynecological Cancer
- GSOR03 Presentation Time: 5:10 PM
- Using Virtual Reality Technology to Improve Patient Anxiety and Reduce Opioids Use during HDR Brachytherapy Procedure for Patients with Gynecological Cancer
- GSOR03 Presentation Time: 5:10 PM
- Using Virtual Reality Technology to Improve Patient Anxiety and Reduce Opioids Use during HDR Brachytherapy Procedure for Patients with Gynecological Cancer
- Using Virtual Reality Technology to Improve Patient Anxiety and Reduce Opioids Use during HDR Brachytherapy Procedure for Patients with Gynecological Cancer
- Using Virtual Reality Technology to Improve Patient Anxiety and Reduce Opioids Use during HDR Brachytherapy Procedure for Patients with Gynecological Cancer
- Using Virtual Reality Technology to Improve Patient Anxiety and Reduce Opioids Use during HDR Brachytherapy Procedure for Patients with Gynecological Cancer
- GSOR03 Presentation Time: 5:10 PM
- GSOR03 Presentation Time: 5:10 PM
- GSOR03 Presentation Time: 5:10 PM
Similar Researchers
Based on overlapping research topics